Credit Cards
Savings
Life Insurance
Car Insurance
Mortgages
Travel Insurance
Loans
Home Insurance
EnergyPick of the early market news
Filed under: Investing
Share
Text Size
A
A
A
S
oon-to-be-wed Xstrata and Glencore International led the falls yesterday, sliding -4.88% and -3.80% respectively. The FTSE 100 finished the day at 5,890, just -0.03% down, though it had spent the majority of the day in the red.
The Dow Jones finished a smidge higher at 12,878, 0.26% higher. Toyota earnings have helped the Nikkei, along with other Japanese car makers.
We start this morning with full-year numbers from International Power. Revenues jumped 3% from €16,502 million (2010: €15,950 million) with adjusted current operating income rising 9% to €3,055 million (2010: €2,810 million).
The company says it is confident of delivering further growth in 2012, principally driven by full year contributions from new plants. However revenue in UK-Europe decreased 4% to €3,618 million compared to €3,752 million last year.
A dip for profits at BHP Billiton. Slipping commodity prices saw the Anglo-Oz player reported a 5.5% slump in first-half net profits, down to £6.2bn. The miner is also warning of slower growth from Asia, notably China. However the profits still remain huge, with group revenues rising almost 10%.
"The first half of the 2012 financial year had its challenges in terms of global economic growth reflecting continued difficulties in Europe and slowing levels of activity in the high growth economies of China and India."
However two bright spots were the US says the company, "which saw stronger growth on the back of robust performance in the manufacturing sector, and Japan, which saw a rebound in activity following the impacts of the March 2011 tsunami."
Lastly, Q4 numbers - an 8% rise in revenues - from Nurofen-to-Dettol-to-Finish maker Reckitt Benckiser. Net revenues in 2011 overall climbed to £9.49bn from £8.45bn. Pre-tax profits accelerated to £2.38bn from £2.14bn in 2010.
"Reckitt Benckiser delivered another strong year, exceeding both our net revenue target (+12%) and adjusted net income target (+10%) in an increasingly tough environment," said the company. "Like-for-like growth of 4% was underpinned by a robust performance in the base business, especially in Q4."
"Growth was driven in particular by excellent growth in emerging markets, and growth in our Powerbrands - Dettol, Nurofen, Mucinex, Strepsils, Gaviscon and Harpic. SSL had a good first year with LFL growth of 6%, although full year growth is flattered by a soft Q4 last year."
oon-to-be-wed Xstrata and Glencore International led the falls yesterday, sliding -4.88% and -3.80% respectively. The FTSE 100 finished the day at 5,890, just -0.03% down, though it had spent the majority of the day in the red.The Dow Jones finished a smidge higher at 12,878, 0.26% higher. Toyota earnings have helped the Nikkei, along with other Japanese car makers.
We start this morning with full-year numbers from International Power. Revenues jumped 3% from €16,502 million (2010: €15,950 million) with adjusted current operating income rising 9% to €3,055 million (2010: €2,810 million).
The company says it is confident of delivering further growth in 2012, principally driven by full year contributions from new plants. However revenue in UK-Europe decreased 4% to €3,618 million compared to €3,752 million last year.
A dip for profits at BHP Billiton. Slipping commodity prices saw the Anglo-Oz player reported a 5.5% slump in first-half net profits, down to £6.2bn. The miner is also warning of slower growth from Asia, notably China. However the profits still remain huge, with group revenues rising almost 10%.
"The first half of the 2012 financial year had its challenges in terms of global economic growth reflecting continued difficulties in Europe and slowing levels of activity in the high growth economies of China and India."
However two bright spots were the US says the company, "which saw stronger growth on the back of robust performance in the manufacturing sector, and Japan, which saw a rebound in activity following the impacts of the March 2011 tsunami."
Lastly, Q4 numbers - an 8% rise in revenues - from Nurofen-to-Dettol-to-Finish maker Reckitt Benckiser. Net revenues in 2011 overall climbed to £9.49bn from £8.45bn. Pre-tax profits accelerated to £2.38bn from £2.14bn in 2010.
"Reckitt Benckiser delivered another strong year, exceeding both our net revenue target (+12%) and adjusted net income target (+10%) in an increasingly tough environment," said the company. "Like-for-like growth of 4% was underpinned by a robust performance in the base business, especially in Q4."
"Growth was driven in particular by excellent growth in emerging markets, and growth in our Powerbrands - Dettol, Nurofen, Mucinex, Strepsils, Gaviscon and Harpic. SSL had a good first year with LFL growth of 6%, although full year growth is flattered by a soft Q4 last year."
